Published in Blood Weekly, July 27th, 2000
"Induction of allogeneic hematopoietic chimerism using sublethal myeloablative conditioning in the absence of graft-vs-host disease (GVHD) is a major goal of stem cell transplantation," reported D.S. Forman and colleagues from the University of Massachusetts Medical School. "We have achieved stable hematopoietic chimerism using BALB/c (H2d) mice given C57BL/6 (H2b) bone marrow cells, low dose irradiation, and a brief course of anti-CD154 MAb to block CD40-CD154...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.